Object recognition test for studying cognitive impairments in animal models of Alzheimer's disease

Frontiers in Bioscience - Scholar

Volumn 7S, Issue 1, 2015, Pages 10-29

  Bengoetxea, Xabier ^a   Rodriguez Perdigon, Manuel ^a   Ramirez, Maria J ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Amyloid beta; Cognition; Review; Sporadic Alzheimer's disease; Tau; Transgenic models

Indexed keywords

AMYLOID BETA PROTEIN; CHOLINERGIC RECEPTOR STIMULATING AGENT; INSULIN; SCOPOLAMINE;

AGING; ALZHEIMER DISEASE; ANIMAL BEHAVIOR; ANIMAL MODEL; ARTICLE; BRAIN REGION; COGNITIVE DEFECT; EPISODIC MEMORY; HUMAN; HYPOPHYSIS ADRENAL SYSTEM; INSULIN RESISTANCE; METHODOLOGY; NEUROPATHOLOGY; NONHUMAN; NOVEL OBJECT RECOGNITION TEST; OLFACTORY BULB; PATHOGENESIS; SENESCENCE; STRESS; TRANSGENIC ANIMAL; ANIMAL; COGNITION DISORDERS; DISEASE MODEL; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGY;

ANIMALIA; RODENTIA;

ALZHEIMER DISEASE; ANIMALS; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; HUMANS; NEUROPSYCHOLOGICAL TESTS;

EID: 84931266653     PISSN: 19450516     EISSN: 19450524     Source Type: Journal    
DOI: 10.2741/s421     Document Type: Article

References (148)

1. Costa N, Ferlicoq L, Derumeaux-Burel H, Rapp T, Garnault V, Gillette-Guyonnet S, Andrieu S, Vellas B, Lamure M, Grand A, Molinier L, Comparison of informal care time and costs in different age-related dementias: a review. BioMed Res Int 2013, 852368 (2013) DOI: 10.1155/2013/852368
2. Serrano-Pozo A, Frosch MP, Masliah E, Hyman BT, Neuropathological Alterations in Alzheimer Disease. Cold Spring Harb Perspect Med 1:a006189 (2011) DOI: 10.1101/cshperspect.a006189
3. Mc Donald JM, Savva GM, Brayne C, Welzel AT, Forster G, Shankar GM, Selkoe DJ, Ince PG, Walsh DM; Medical Research Council Cognitive Function and Ageing Study, The presence of sodium dodecyl sulphate-stable A beta dimers is strongly associated with Alzheimer-type dementia. Brain J Neurol 133, 1328-1341 (2010) DOI: 10.1093/brain/awq065
4. Schneider LS, Mangialasche F, Andreasen N, Feldman H, Giacobini E, Jones R, Mantua V, Mecocci P, Pani L, Winblad B, Kivipelto M. Clinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014. J Intern Med 275, 251-283 (2014) DOI: 10.1111/joim.12191
5. Nestor PJ, Scheltens P, Hodges JR, Advances in the early detection of Alzheimer's disease. Nat Med 10 Suppl, S34-41 (2004) DOI: 10.1038/nrn1433
6. Aggleton J, Brown M, Episodic memory, amnesia, and the hippocampal-anterior thalamic axis. Behav Brain Sci 22, 425-489 (1999) DOI: 10.1017/S0140525X99002034
7. Burgess N, Maguire EA, O'Keefe J, The human hippocampus and spatial and episodic memory. Neuron 35, 625-641 (2002) DOI: 10.1016/S0896-6273(02)00830-9
8. Puzzo D, Lee L, Palmeri A, Calabrese G, Arancio O, Behavioral assays with mouse models of Alzheimer's disease: Practical considerations and guidelines. Biochem Pharmacol 88, 450-467 (2014) DOI: 10.1016/j.bcp.2014.01.011
9. Webster SJ, Bachstetter AD, Nelson PT, Schmitt FA, Van Eldik LJ, Using mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models. Front Genet 5, 88 (2014) DOI: 10.3389/fgene.2014.00088
10. Ennaceur A, Delacour J, A new one-trial test for neurobiological studies of memory in rats. 1: Behavioral data. Behav Brain Res 31, 47-59 (1988) DOI: 10.1016/0166-4328(88)90157-X
11. Mumby DG, Gaskin S, Glenn MJ, Schramek TE, Lehmann H, Hippocampal damage and exploratory preferences in rats: memory for objects, places, and contexts. Learn Mem Cold Spring Harb 9, 49-57 (2002) DOI: 10.1101/lm.41302
12. Dere E, Huston JP, De Souza Silva MA, The pharmacology, neuroanatomy and neurogenetics of one-trial object recognition in rodents. Neurosci Biobehav Rev 31, 673-704 (2007) DOI: 10.1016/j.neubiorev.2007.01.005
13. Akkerman S, Blokland A, Reneerkens O, van Goethem NP, Bollen E, Gijselaers HJM, Lieben CK, Steinbusch HW, Prickaerts J, Object recognition testing: Methodological considerations on exploration and discrimination measures. Behav Brain Res 232, 335-347 (2012) DOI: 10.1016/j.bbr.2012.03.022
14. Bevins RA, Besheer J, Object recognition in rats and mice: a one-trial non-matching-to-sample learning task to study "recognition memory." Nat Protoc 1, 1306-11 (2006) DOI: 10.1038/nprot.2006.205
15. Gaffan D, Harrison S, Reversal learning by fornix-transected monkeys. J Exp Psychol 36, 223-234 (1984) DOI: 10.1080/14640748408402204
16. Zola-Morgan S, Squire LR, Medial temporal lesions in monkeys impair memory on a variety of tasks sensitive to human amnesia. Behav Neurosci 99, 22-34 (1985) DOI: 10.1037/0735-7044.99.1.22
17. Antunes M, Biala G, The novel object recognition memory: neurobiology, test procedure, and its modifications. Cogn Process 13, 93-110 (2012) DOI: 10.1007/s10339-011-0430-z
18. Piterkin P, Cole E, Cossette M-P, Gaskin S, Mumby DG, A limited role for the hippocampus in the modulation of novel-object preference by contextual cues. Learn Mem Cold Spring Harb 15, 785-791 (2008) DOI: 10.1101/lm.1035508
19. Reger ML, Hovda DA, Giza CC, Ontogeny of Rat Recognition Memory measured by the novel object recognition task. Dev Psychobiol 51, 672-678 (2009) DOI: 10.1002/dev.20402
20. Ennaceur A, One-trial object recognition in rats and mice: methodological and theoretical issues. Behav Brain Res 215, 244-54 (2010) DOI: 10.1016/j.bbr.2009.12.036
21. Aggleton J, One-trial object recognition by rats. J Exp Psychol 37, 279-294 (1985) DOI: 10.1080/14640748508401171
22. Eilam D, Golani I, Home base behavior of rats (Rattus norvegicus) exploring a novel environment. Behav Brain Res 34, 199-211 (1989) DOI: 10.1016/S0166-4328(89)80102-0
23. Burke SN, Wallace JL, Nematollahi S, Uprety AR, Barnes CA, Pattern separation deficits may contribute to age-associated recognition impairments. Behav Neurosci 124, 559-573 (2010) DOI: 10.1037/a0020893
24. Aggleton J, Albasser M, Aggleton D, Tarozzo G, Pearce J, Lesions of the rat perirhinal cortex spare the acquisition of a complex configural visual discrimination yet impair object recognition. Behav Neurosci 124, 55-68 (2010) DOI: 10.1037/a0018320
25. Oliveira AMM, Hawk JD, Abel T, Havekes R, Post-training reversible inactivation of the hippocampus enhances novel object recognition memory. Learn Mem Cold Spring Harb N 17, 155-160 (2010) DOI: 10.1101/lm.1625310
26. Gaskin S, Tardif M, Cole E, Piterkin P, Kayello L, Mumby DG, Object familiarization and novel-object preference in rats. Behav Processes 83, 61-71 (2010) DOI: 10.1016/j.beproc.2009.10.003
27. Schindler AG, Li S, Chavkin C, Behavioral stress may increase the rewarding valence of cocaine-associated cues through a dynorphin/kappa-opioid receptor-mediated mechanism without affecting associative learning or memory retrieval mechanisms. Neuropsychopharmacol 35, 1932-1942 (2010) DOI: 10.1038/npp.2010.67
28. Wang D, Noda Y, Zhou Y, Mouri A, Mizoguchi H, Nitta A, Chen W, Nabeshima T, The allosteric potentiation of nicotinic acetylcholine receptors by galantamine ameliorates the cognitive dysfunction in beta amyloid25-35 i.c.v.-injected mice: involvement of dopaminergic systems. Neuropsychopharmacol 32, 1261-1271 (2007) DOI: 10.1038/sj.npp.1301256
29. Hammond RS, Tull LE, Stackman RW, On the delay-dependent involvement of the hippocampus in object recognition memory. Neurobiol Learn Mem 82, 26-34 (2004) DOI: 10.1016/j.nlm.2004.03.005
30. Knowles JK, Simmons DA, Nguyen T-VV, Vander Griend L, Xie Y, Zhang H, Yang T, Pollak J, Chang T, Arancio O, Buckwalter MS, Wyss-Coray T, Massa SM, Longo FM, A small molecule p75NTR ligand prevents cognitive deficits and neurite degeneration in an Alzheimer's mouse model. Neurobiol Aging 34, 2052-2063 (2013) DOI: 10.1016/j.neurobiolaging.2013.02.015
31. Zhang R, Xue G, Wang S, Zhang L, Shi C, Xie X, Novel object recognition as a facile behavior test for evaluating drug effects in A beta PP/PS1 Alzheimer's disease mouse model. J Alzheimers Dis 31, 801-812 (2012) No DOI Found
32. Martin-Moreno AM, Brera B, Spuch C, Carro E, Garcia-Garcia L, Delgado M, Pozo MA, Innamorato NG, Cuadrado A, de Ceballos ML, Prolonged oral cannabinoid administration prevents neuroinflammation, lowers beta amyloid levels and improves cognitive performance in Tg APP 2576 mice. J Neuroinflammation 9, 8 (2012) DOI: 10.1186/1742-2094-9-8
33. Platano D, Fattoretti P, Balietti M, Bertoni-Freddari C, Aicardi G, Long-term visual object recognition memory in aged rats. Rejuvenation Res 11, 333-339 (2008) DOI: 10.1089/rej.2008.0687
34. Leger M, Quiedeville A, Bouet V, Haelewyn B, Boulouard M, Schumann-Bard P, Freret T, Object recognition test in mice. Nat Protoc 8, 2531-2537 (2013) DOI: 10.1038/nprot.2013.155
35. Ennaceur A, Neave N, Aggleton J, Spontaneous object recognition and object location memory in rats: the effects of lesions in the cingulate cortices, the medial prefrontal cortex, the cingulum bundle and the fornix. Exp Brain Res 113, 509-519 (1997) DOI: 10.1007/PL00005603
36. Gao S, Hendrie H, Hall K, Hui S, The relationships between age, sex, and the incidence of dementia and alzheimer disease: A meta-analysis. Arch Gen Psychiatry 55, 809-815 (1988) DOI: 10.1001/archpsyc.55.9.809
37. Bartolini L, Casamenti F, Pepeu G, Aniracetam restores object recognition impaired by age, scopolamine, and nucleus basalis lesions. Pharmacol Biochem Behav 53, 277-283 (1996) DOI: 10.1016/0091-3057(95)02021-7
38. Solas M, Aisa B, Mugueta M, Del Río J, Tordera RM, Ramírez MJ, Interactions between age, stress and insulin on cognition: implications for Alzheimer's disease. Neuropsychopharmacol 35, 1664-1673 (2010)
39. Tulving E, Markowitsch HJ, Episodic and declarative memory: role of the hippocampus. Hippocampus 8, 198-204 (1998) DOI: 10.1002/(SICI)1098-1063(1998)8:3〈198::AID-HIPO2〉3.3.CO;2-J DOI: 10.1002/(SICI)1098-1063(1998)8:3〈198::AID-HIPO2〉3.0.CO;2-G
40. Bäckman L, Jones S, Berger A-K, Laukka EJ, Small BJ, Cognitive impairment in preclinical Alzheimer's disease: a meta-analysis. Neuropsychology 19, 520-531 (2005) DOI: 10.1037/0894-4105.19.4.520
41. Dere E, Huston JP, De Souza Silva MA, Episodic-like memory in mice: Simultaneous assessment of object, place and temporal order memory. Brain Res Protoc 16, 10-19 (2005) DOI: 10.1016/j.brainresprot.2005.08.001
42. Eacott MJ, Norman G, Integrated memory for object, place, and context in rats: a possible model of episodic-like memory?. J Neurosci 24, 1948-1953 (2004) DOI: 10.1523/JNEUROSCI.2975-03.2004
43. Davis KE, Easton A, Eacott MJ, Gigg J, Episodic-Like Memory for What-Where-Which Occasion is Selectively Impaired in the 3xTgAD Mouse Model of Alzheimer's Disease. J Alzheimers Dis 33, 681-698 (2013) No DOI Found
44. Dodart JC, Mathis C, Ungerer A, Scopolamine-induced deficits in a two-trial object recognition task in mice. Neuroreport 8, 1173-1178 (1997) DOI: 10.1097/00001756-199703240-00023
45. Messier C, Object recognition in mice: improvement of memory by glucose. Neurobiol Learn Mem 67, 172-175 (1997) DOI: 10.1006/nlme.1996.3755
46. Steckler T, Weis C, Sauvage M, Mederer A, Holsboer F, Disrupted allocentric but preserved egocentric spatial learning in transgenic mice with impaired glucocorticoid receptor function. Behav Brain Res 100, 77-89 (1999) DOI: 10.1016/S0166-4328(98)00115-6
47. Dere E, Silva MADS, Huston JP, Higher order memories for objects encountered in different spatio-temporal contexts in mice: evidence for episodic memory. Rev Neurosci 15, 231-240 (2004) DOI: 10.1515/REVNEURO.2004.15.4.231
48. Bertaina-Anglade V, Enjuanes E, Morillon D, Drieu la Rochelle C, The object recognition task in rats and mice: a simple and rapid model in safety pharmacology to detect amnesic properties of a new chemical entity. J Pharmacol Toxicol Methods 54, 99-105 (2006) DOI: 10.1016/j.vascn.2006.04.001
49. Buckmaster CA, Eichenbaum H, Amaral DG, Suzuki WA, Rapp PR, Entorhinal cortex lesions disrupt the relational organization of memory in monkeys. J Neurosci 24, 9811-9825 (2004) DOI: 10.1523/JNEUROSCI.1532-04.2004
50. Clark RE, Zola SM, Squire LR, Impaired recognition memory in rats after damage to the hippocampus. J Neurosci 20, 8853-8860 (2000)
51. Clarke JR, Cammarota M, Gruart A, Izquierdo I, Delgado-García JM, Plastic modifications induced by object recognition memory processing. Proc Natl Acad Sci U S A 107, 2652-2657 (2010) DOI: 10.1073/pnas.0915059107
52. Norman G, Eacott MJ, Dissociable effects of lesions to the perirhinal cortex and the postrhinal cortex on memory for context and objects in rats. Behav Neurosci 119, 557-566 (2005) DOI: 10.1037/0735-7044.119.2.557
53. Kivisaari SL, Tyler LK, Monsch AU, Taylor KI, Medial perirhinal cortex disambiguates confusable objects. Brain J Neurol 135, 3757-3769 (2012) DOI: 10.1093/brain/aws277
54. Witter MP, Naber PA, van Haeften T, Machielsen WCM, Rombouts SARB, Barkhof F, Scheltens P, Lopes da Silva FH, Corticohippocampal communication by way of parallel parahippocampal-subicular pathways. Hippocampus 10, 398-410 (2000) DOI: 10.1002/1098-1063(2000)10:4〈398::AID-HIPO6〉3.0.CO;2-K DOI: 10.1002/1098-1063(2000)10:4〈398::AID-HIPO6〉3.3.CO;2-B
55. Sargolini F, Roullet P, Oliverio A, Mele A, Effects of intra-accumbens focal administrations of glutamate antagonists on object recognition memory in mice. Behav Brain Res 138, 153-163 (2003) DOI: 10.1016/S0166-4328(02)00238-3
56. Yilmazer-Hanke DM, Hanke J, Progression of Alzheimer-related neuritic plaque pathology in the entorhinal region, perirhinal cortex and hippocampal formation. Dement Geriatr Cogn Disord 10:70-76 (1999) DOI: 10.1159/000017104
57. Thal D, Rüb U, Orantes M, Braak H, Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 58:1791-1800 (2002) DOI: 10.1212/WNL.58.12.1791
58. Thal DR, Rüb U, Schultz C, Sassin I, Ghebremedhin E, Del Tredici K, Braak E, Braak H, Sequence of A beta-protein deposition in the human medial temporal lobe. J Neuropathol Exp Neurol 59, 733-748 (2000)
59. Braak E, Braak H, Silver staining method for demonstrating Lewy bodies in Parkinson's disease and argyrophilic oligodendrocytes in multiple system atrophy. J Neurosci Methods 87:111-115 (1999) DOI: 10.1016/S0165-0270(98)00173-3
60. Mustafiz T, Portelius E, Gustavsson MK, Hölttä M, Zetterberg H, Blennow K, Nordberg A, Lithner CU, Characterization of the brain beta -amyloid isoform pattern at different ages of Tg2576 mice. Neurodegener Dis 8, 352-363 (2011) DOI: 10.1159/000323871
61. Tamagnini F, Burattini C, Casoli T, Balietti M, Fattoretti P, Aicardi G, Early impairment of long-term depression in the perirhinal cortex of a mouse model of Alzheimer's disease. Rejuvenation Res 15, 231-234 (2012) DOI: 10.1089/rej.2011.1311
62. Barker GRI, Warburton EC, When Is the Hippocampus Involved in Recognition Memory? J Neurosci 31, 10721-10731 (2011) DOI: 10.1523/JNEUROSCI.6413-10.2011
63. Paban V, Jaffard M, Chambon C, Malafosse M, Alescio-Lautier B, Time course of behavioral changes following basal forebrain cholinergic damage in rats: Environmental enrichment as a therapeutic intervention. Neuroscience 132,13-32 (2005) DOI: 10.1523/JNEUROSCI.6413-10.2011
64. Roullet P, Sargolini F, Oliverio A, Mele A, NMDA and AMPA antagonist infusions into the ventral striatum impair different steps of spatial information processing in a nonassociative task in mice. J Neurosci 21, 2143-2149 (2001) No DOI Found
65. Sato E, Oda N, Ozaki N, Hashimoto S, Kurokawa T, Ishibashi S, Early and transient increase in oxidative stress in the cerebral cortex of senescence-accelerated mouse. Mech Ageing Dev 86, 105-114 (1996) DOI: 10.1016/0047-6374(95)01681-3
66. Jiang T, Yu J-T, Tian Y, Tan L, Epidemiology and etiology of Alzheimer's disease: from genetic to non-genetic factors. Curr Alzheimer Res 10, 852-867 (2013) DOI: 10.2174/15672050113109990155
67. Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, Guillozet-Bongaarts A, Ohno M, Disterhoft J, Van Eldik L, Berry R, Vassar R, Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation. J Neurosci 26, 10129-10140 (2006) DOI: 10.1523/JNEUROSCI.1202-06.2006
68. Lecanu L, Papadopoulos V, Modeling Alzheimer's disease with non-transgenic rat models. Alzheimers Res Ther 5, 17 (2013) No DOI Found
69. Games D, Adams D, Alessandrini R, Barbour R, Berthelette P, Blackwell C, Carr T, Clemens J, Donaldson T, Gillespie F, Guido T, Hagopian S, ohnson-Wood K, Khan K, Lee M, Leibowitz P, Lieberburg I, Little S, Masliah E, McConlogue L, Montoya-Zavala M, Mucke L, Paganini L, Penniman E, Power M, Schenk D, Seubert P, Snyder B, Soriano F, Tan H, Vitale J, Wadsworth S, Wolozin B, Zhao J, Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature 373, 523-527 (1995) DOI: 10.1038/373523a0
70. Gerlai R, Gene targeting: technical confounds and potential solutions in behavioral brain research. Behav Brain Res 125, 13-21 (2001) DOI: 10.1016/S0166-4328(01)00282-0
71. Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, Yang F, Cole G, Correlative memory deficits, A beta elevation, and amyloid plaques in transgenic mice. Science 274, 99-102 (1996) DOI: 10.1126/science.274.5284.99
72. Chapman PF, White GL, Jones MW, Cooper-Blacketer D, Marshall VJ, Irizarry M, Younkin L, Good MA, Bliss TV, Hyman BT, Younkin SG, Hsiao KK, Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice. Nat Neurosci 2, 271-276 (1999) DOI: 10.1038/6374
73. Ohta H, Arai S, Akita K, Ohta T, Fukuda S, Effects of NK-4 in a Transgenic Mouse Model of Alzheimer's Disease. PLoS One 7 (2012) No DOI Found
74. Taglialatela G, Hogan D, Zhang W-R, Dineley KT, Intermediate- and long-term recognition memory deficits in Tg2576 mice are reversed with acute calcineurin inhibition. Behav Brain Res 200, 95-99 (2009) DOI: 10.1016/j.bbr.2008.12.034
75. Dobarro M, Gerenu G, Ramírez MJ, Propranolol reduces cognitive deficits, amyloid and tau pathology in Alzheimer's transgenic mice. Int J Neuropsychopharmacol 16, 2245-2257 (2013) DOI: 10.1017/S1461145713000631
76. Mouri A, Noda Y, Hara H, Mizoguchi H, Tabira T, Nabeshima T, Oral vaccination with a viral vector containing A beta cDNA attenuates age-related A beta accumulation and memory deficits without causing inflammation in a mouse Alzheimer model. FASEB J 21, 2135-2148 (2007) DOI: 10.1096/fj.06-7685com
77. Gerenu G, Dobarro M, Ramirez MJ, Gil-Bea FJ, Early cognitive stimulation compensates for memory and pathological changes in Tg2576 mice. Biochim Biophys Acta 1832, 837-847 (2013) DOI: 10.1016/j.bbadis.2013.02.018
78. Hale G, Good M, Impaired visuospatial recognition memory but normal object novelty detection and relative familiarity judgments in adult mice expressing the APPswe Alzheimer's disease mutation. Behav Neurosci 119, 884-891 (2005) DOI: 10.1016/j.bbadis.2013.02.018
79. Lee ACH, Rahman S, Hodges JR, Sahakian BJ, Graham KS, Associative and recognition memory for novel objects in dementia: implications for diagnosis. Eur J Neurosci 18, 1660-1670 (2003) DOI: 10.1046/j.1460-9568.2003.02883.x
80. Mucke L, Masliah E, Yu GQ, Mallory M, Rockenstein EM, Tatsuno G, Hu K, Kholodenko D, Johnson-Wood K, McConlogue L, High-level neuronal expression of A beta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J Neurosci 20, 4050-4058 (2000) No DOI Found
81. Harris JA, Devidze N, Halabisky B, Lo I, Thwin MT, Yu G-Q, Bredesen DE, Masliah E, Mucke L, Many neuronal and behavioral impairments in transgenic mouse models of Alzheimer's disease are independent of caspase cleavage of the amyloid precursor protein. J Neurosci 30, 372-381 (2010) DOI: 10.1523/JNEUROSCI.5341-09.2010
82. Escribano L, Simón A-M, Pérez-Mediavilla A, Salazar-Colocho P, Del Río J, Frechilla D, Rosiglitazone reverses memory decline and hippocampal glucocorticoid receptor down-regulation in an Alzheimer's disease mouse model. Biochem Biophys Res Commun 379, 406-410 (2009) DOI: 10.1016/j.bbrc.2008.12.071
83. Simón A-M, Schiapparelli L, Salazar-Colocho P, Cuadrado-Tejedor M, Escribano L, López de Maturana R, Del Río J, Pérez-Mediavilla A, Frechilla D, Overexpression of wild-type human APP in mice causes cognitive deficits and pathological features unrelated to A beta levels. Neurobiol Dis 33, 369-378 (2009) DOI: 10.1016/j.nbd.2008.11.005
84. Cissé M, Sanchez PE, Kim DH, Ho K, Yu G-Q, Mucke L, Ablation of cellular prion protein does not ameliorate abnormal neural network activity or cognitive dysfunction in the J20 line of human amyloid precursor protein transgenic mice. J Neurosci 31, 10427-10431 (2011) DOI: 10.1523/JNEUROSCI.1459-11.2011
85. Karl T, Bhatia S, Cheng D, Kim WS, Garner B, Cognitive phenotyping of amyloid precursor protein transgenic J20 mice. Behav Brain Res 228, 392-397 (2012) DOI: 10.1016/j.bbr.2011.12.021
86. Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Metherate R, Mattson MP, Akbari Y, LaFerla FM, Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular A beta and synaptic dysfunction. Neuron 39, 409-421 (2003) DOI: 10.1016/S0896-6273(03)00434-3
87. Filali M, Lalonde R, Theriault P, Julien C, Calon F, Planel E, Cognitive and non-cognitive behaviors in the triple transgenic mouse model of Alzheimer's disease expressing mutated APP, PS1, and Mapt (3xTg-AD). Behav Brain Res 234, 334-342 (2012) DOI: 10.1016/j.bbr.2012.07.004
88. Masciopinto F, Di Pietro N, Corona C, Bomba M, Pipino C, Curcio M, Di Castelnuovo A, Ciavardelli D, Silvestri E, Canzoniero LM, Sekler I, Pandolfi A, Sensi SL, Effects of long-term treatment with pioglitazone on cognition and glucose metabolism of PS1-KI, 3xTg-AD, and wild-type mice. Cell Death Dis 3, e448 (2012) DOI: 10.1038/cddis.2012.189
89. Onishi T, Iwashita H, Uno Y, Kunitomo J, Saitoh M, Kimura E, Fujita H, Uchiyama N, Kori M, Takizawa M, A novel glycogen synthase kinase-3 inhibitor 2-methyl-5-(3-{4-((S) -methylsulfinyl)phenyl}-1-benzofuran-5-yl)-1,3,4-oxadiazole decreases tau phosphorylation and ameliorates cognitive deficits in a transgenic model of Alzheimer's disease. J Neurochem 119, 1330-1340 (2011) DOI: 10.1111/j.1471-4159.2011.07532.x
90. Arsenault D, Julien C, Tremblay C, Calon F, DHA improves cognition and prevents dysfunction of entorhinal cortex neurons in 3xTg-AD mice. PloS One 6, e17397 (2011) DOI: 10.1371/journal.pone.0017397
91. Green KN, Steffan JS, Martinez-Coria H, Sun X, Schreiber SS, Thompson LM, LaFerla FM, Nicotinamide restores cognition in Alzheimer's disease transgenic mice via a mechanism involving sirtuin inhibition and selective reduction of Thr231-phosphotau. J Neurosci 28, 11500-11510 (2008) DOI: 10.1523/JNEUROSCI.3203-08.2008
92. St-Amour I, Paré I, Tremblay C, Coulombe K, Bazin R, Calon F, IVIg protects the 3xTg-AD mouse model of Alzheimer's disease from memory deficit and A beta pathology. J Neuroinflammation 11, 54 (2014) DOI: 10.1186/1742-2094-11-54
93. 3-MARRS/Pdia3/ERp57 and improves Alzheimer's disease pathologies in 5XFAD mice. Sci Rep 2, 535 (2012) DOI: 10.1038/srep00535
94. Giannoni P, Gaven F, de Bundel D, Baranger K, Marchetti-Gauthier E, Roman FS, Valjent E, Marin P, Bockaert J, Rivera S, Claeysen S, Early administration of RS 67333, a specific 5-HT4 receptor agonist, prevents amyloidogenesis and behavioral deficits in the 5XFAD mouse model of Alzheimer's disease. Front Aging Neurosci 5, 96 (2013) DOI: 10.3389/fnagi.2013.00096
95. Lesuisse C, Xu G, Anderson J, Wong M, Jankowsky J, Holtz G, Gonzalez V, Wong PC, Price DL, Tang F, Wagner S, Borchelt DR, Hyper-expression of human apolipoprotein E4 in astroglia and neurons does not enhance amyloid deposition in transgenic mice. Hum Mol Genet 10, 2525-2537 (2001) DOI: 10.1093/hmg/10.22.2525
96. Savonenko A, Xu GM, Melnikova T, Morton JL, Gonzales V, Wong MPF, Price DL, Tang F, Markowska AL, Borchelt DR, Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease: relationships to beta-amyloid deposition and neurotransmitter abnormalities. Neurobiol Dis 18, 602-617 (2005) DOI: 10.1016/j.nbd.2004.10.022
97. Garcia-Alloza M, Robbins EM, Zhang-Nunes SX, Purcell SM, Betensky RA, Raju S, Prada C, Greenberg SM, Bacskai BJ, Frosch MP, Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease. Neurobiol Dis 24, 516-524 (2006) DOI: 10.1016/j.nbd.2006.08.017
98. Donkin JJ, Stukas S, Hirsch-Reinshagen V, Namjoshi D, Wilkinson A, May S, Chan J, Fan J, Collins J, Wellington CL, ATP-binding Cassette Transporter A1 Mediates the Beneficial Effects of the Liver X Receptor Agonist GW3965 on Object Recognition Memory and Amyloid Burden in Amyloid Precursor Protein/Presenilin 1 Mice. J Biol Chem 285, 34144-34154 (2010) DOI: 10.1074/jbc.M110.108100
99. Cheng D, Low JK, Logge W, Garner B, Karl T, Novel behavioural characteristics of female APPSwe/PS1ΔE9 double transgenic mice. Behav Brain Res 260, 111-118 (2014) DOI: 10.1016/j.bbr.2013.11.046
100. Bollen E, Vanmierlo T, Akkerman S, Wouters C, Steinbusch HMW, Prickaerts J, 7,8-Dihydroxyflavone improves memory consolidation processes in rats and mice. Behav Brain Res 257, 8-12 (2013) DOI: 10.1016/j.bbr.2013.09.029
101. Sierksma AS, van den Hove DL, Pfau F, Philippens M, Bruno O, Fedele E, Ricciarelli R, Steinbusch HW, Vanmierlo T, Prickaerts J, Improvement of spatial memory function in APPswe/PS1dE9 mice after chronic inhibition of phosphodiesterase type 4D. Neuropharmacology 77, 120-130 (2014) DOI: 10.1016/j.neuropharm.2013.09.015
102. Toledano A, Alvarez MI, Lesions and dysfunctions of the nucleus basalis as Alzheimer's disease models: general and critical overview and analysis of the long-term changes in several excitotoxic models. Curr Alzheimer Res 1, 189-214 (2004) DOI: 10.2174/1567205043332117
103. Davies P, Challenging the cholinergic hypothesis in Alzheimer disease. JAMA 281, 1433-1434 (1999) DOI: 10.1001/jama.281.15.1433
104. 1-42in mice novel object and object location recognition tasks. Neuropharmacology 70, 261-267 (2013) DOI: 10.1016/j.neuropharm.2013.02.002
105. De Bruin N, Pouzet B, Beneficial effects of galantamine on performance in the object recognition task in Swiss mice: deficits induced by scopolamine and by prolonging the retention interval. Pharmacol Biochem Behav 85, 253-260 (2006) DOI: 10.1016/j.pbb.2006.08.007
106. Uslaner JM, Eddins D, Puri V, Cannon CE, Sutcliffe J, Chew CS, Pearson M, Vivian JA, Chang RK, Ray WJ, Kuduk SD, Wittmann M, The muscarinic M1 receptor positive allosteric modulator PQCA improves cognitive measures in rat, cynomolgus macaque, and rhesus macaque. Psychopharmacology 225, 21-30 (2013) DOI: 10.1007/s00213-012-2788-8
107. Capurro V, Busquet P, Lopes JP, Bertorelli R, Tarozzo G, Bolognesi ML, Piomelli D, Reggiani A, Cavalli A, Pharmacological Characterization of Memoquin, a Multi-Target Compound for the Treatment of Alzheimer's Disease. PLoS One 8 e56870 (2013) DOI: 10.1371/journal.pone.0056870
108. Luques L, Shoham S, Weinstock M, Chronic brain cytochrome oxidase inhibition selectively alters hippocampal cholinergic innervation and impairs memory: Prevention by ladostigil. Exp Neurol 206, 209-219 (2007) DOI: 10.1016/j.expneurol.2007.04.007
109. Cai L, Gibbs RB, Johnson DA, Recognition of novel objects and their location in rats with selective cholinergic lesion of the medial septum. Neurosci Lett 506, 261-265 (2012) DOI: 10.1016/j.neulet.2011.11.019
110. Kelly JP, Wrynn AS, Leonard BE, The olfactory bulbectomized rat as a model of depression: An update. Pharmacol Ther 74, 299-316 (1997) DOI: 10.1016/S0163-7258(97)00004-1
111. Aleksandrova IY, Kuvichkin VV, Kashparov IA, Medvinskaya NI, Nesterova IV, Lunin SM, Samokhin AN, Bobkova NV, Increased level of beta-amyloid in the brain of bulbectomized mice. Biochemistry 69, 176-180 (2004) No DOI Found
112. Moriguchi S, Tagashira H, Sasaki Y, Yeh JZ, Sakagami H, Narahashi T, Fukunaga K, CaMKII activity is essential for improvement of memory-related behaviors by chronic rivastigmine treatment. J Neurochem 128, 927-937 (2014) DOI: 10.1111/jnc.12510
113. Yankner BA, Duffy LK, Kirschner DA, Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. Science 250, 279-282 (1990) DOI: 10.1126/science.2218531
114. Meunier J, Villard V, Givalois L, Maurice T, The gamma-secretase inhibitor 2-((1R)-1-((4-chlorophenyl)sulfonyl)(2,5-difluorophenyl) amino)ethyl-5-fluorobenzenebutanoic acid (BMS-299897) alleviates A beta 1-42 seeding and short-term memory deficits in the A beta 25-35 mouse model of Alzheimer's disease. Eur J Pharmacol 698, 193-199 (2013) DOI: 10.1016/j.ejphar.2012.10.033
115. Gomes GM, Dalmolin GD, Cordeiro M, Gomez MV, Ferreira J, Rubin MA, The selective A-type K+ current blocker Tx3-1 isolated from the Phoneutria nigriventer venom enhances memory of naïve and A beta 25-35-treated mice. Toxicon 76, 23-27 (2013) DOI: 10.1016/j.toxicon.2013.08.059
116. Tsunekawa H, Noda Y, Mouri A, Yoneda F, Nabeshima T, Synergistic effects of selegiline and donepezil on cognitive impairment induced by amyloid beta (25-35). Behav Brain Res 190, 224-232 (2008) DOI: 10.1016/j.bbr.2008.03.002
117. Lu P, Mamiya T, Lu L, Mouri A, Zou L, Nagai T, Hiramatsu M, Ikejima T, Nabeshima T, Silibinin prevents amyloid beta peptide-induced memory impairment and oxidative stress in mice. Br J Pharmacol 157, 1270-1277 (2009) DOI: 10.1111/j.1476-5381.2009.00295.x
118. D'Agostino G, Russo R, Avagliano C, Cristiano C, Meli R, Calignano A, Palmitoylethanolamide Protects Against the Amyloid-beta 25-35-Induced Learning and Memory Impairment in Mice, an Experimental Model of Alzheimer Disease. Neuropsychopharmacology 37, 1784-1792 (2012) DOI: 10.1038/npp.2012.25
119. Skoog I, Vascular aspects in Alzheimer's disease. J Neural Transm 59, 37-43 (2000) No DOI Found
120. Choi B-R, Lee SR, Han J-S, Woo S-K, Kim KM, Choi D-H, Kwon KJ, Han SH, Shin CY, Lee J, Chung CS, Lee SR, Kim HY, Synergistic memory impairment through the interaction of chronic cerebral hypoperfusion and amlyloid toxicity in a rat model. Stroke 42, 2595-2604 (2011) DOI: 10.1161/STROKEAHA.111.620179
121. Sipos E, Kurunczi A, Kasza Á, Horváth J, Felszeghy K, Laroche S, Toldi J, Párducz A, Penke B, Penke Z, beta -Amyloid pathology in the entorhinal cortex of rats induces memory deficits: Implications for Alzheimer's disease. Neurosci 147, 28-36 (2007) DOI: 10.1016/j.neuroscience.2007.04.011
122. Ito K, Frontiers of model animals for neuroscience: two prosperous aging model animals for promoting neuroscience research. Exp Anim 62, 275-280 (2013) DOI: 10.1538/expanim.62.275
123. Palmeri A, Privitera L, Giunta S, Loreto C, Puzzo D, Inhibition of phosphodiesterase-5 rescues age-related impairment of synaptic plasticity and memory. Behav Brain Res 240, 11-20 (2013) DOI: 10.1016/j.bbr.2012.10.060
124. Scali C, Giovannini MG, Bartolini L, Prosperi C, Hinz V, Schmidt B, Pepeu G, Effect of metrifonate on extracellular brain acetylcholine and object recognition in aged rats. Eur J Pharmacol 325, 173-180 (1997) DOI: 10.1016/S0014-2999(97)00128-3
125. Pallas M, Camins A, Smith MA, Perry G, Lee H, Casadesus G, From aging to Alzheimer's disease: unveiling "the switch" with the senescence-accelerated mouse model (SAMP8). J Alzheimers Dis 15, 615-624 (2008) No DOI Found
126. Sureda FX, Gutierrez-Cuesta J, Romeu M, Mulero M, Canudas AM, Camins A, Mallol J, Pallàs M, Changes in oxidative stress parameters and neurodegeneration markers in the brain of the senescence-accelerated mice SAMP-8. Exp Gerontol 41, 360-367 (2006) DOI: 10.1016/j.exger.2006.01.015
127. Takeda T, Senescence-accelerated mouse (SAM): a biogerontological resource in aging research. Neurobiol Aging 20, 105-110 (1999) DOI: 10.1016/S0197-4580(99)00008-1
128. Morley JE, Farr SA, Kumar VB, Armbrecht HJ, The SAMP8 mouse: a model to develop therapeutic interventions for Alzheimer's disease. Curr Pharm Des 18, 1123-1130 (2012) DOI: 10.2174/138161212799315795
129. Adler BL, Yarchoan M, Hwang HM, Louneva N, Blair JA, Palm R, Smith MA, Lee HG, Arnold SE, Casadesus G, Neuroprotective effects of the amylin analogue pramlintide on Alzheimer's disease pathogenesis and cognition. Neurobiol Aging 35, 793-801 (2014) DOI: 10.1016/j.neurobiolaging.2013.10.076
130. Dobarro M, Orejana L, Aguirre N, Ramírez MJ, Propranolol restores cognitive deficits and improves amyloid and Tau pathologies in a senescence-accelerated mouse model. Neuropharmacology 64, 137-144 (2013) DOI: 10.1016/j.neuropharm.2012.06.047
131. Wilson RS, Barnes LL, Bennett DA, Li Y, Bienias JL, Mendes de Leon CF, Evans DA, Proneness to psychological distress and risk of Alzheimer disease in a biracial community. Neurology 64, 380-382 (2005) DOI: 10.1212/01.WNL.0000149525.53525.E7
132. Ownby RL, Crocco E, Acevedo A, John V, Loewenstein D, Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis. Arch Gen Psychiatry 63, 530-538 (2006) DOI: 10.1001/archpsyc.63.5.530
133. Gil-Bea FJ, Aisa B, Solomon A, Solas M, Mugueta MC, Winblad B, Kivipelto M, Cedazo-Mínguez A, Ramírez MJ, HPA axis dysregulation associated to apolipoprotein E4 genotype in Alzheimer's disease. J Alzheimers Dis 22, 829-838 (2010) No DOI Found
134. Popp J, Schaper K, Kölsch H, Cvetanovska G, Rommel F, Klingmüller D, Dodel R, Wüllner U, Jessen F, CSF cortisol in Alzheimer's disease and mild cognitive impairment. Neurobiol Aging 30, 498-500 (2009) DOI: 10.1016/j.neurobiolaging.2007.07.007
135. Csernansky JG, Dong H, Fagan AM, Wang L, Xiong C, Holtzman DM, Morris JC, Plasma cortisol and progression of dementia in subjects with Alzheimer-type dementia. Am J Psychiatry 163, 2164-2169 (2006) DOI: 10.1176/appi.ajp.163.12.2164
136. Catania C, Sotiropoulos I, Silva R, Onofri C, Breen KC, Sousa N, Almeida OF, The amyloidogenic potential and behavioral correlates of stress. Mol Psychiatry 14, 95-105 (2009) DOI: 10.1038/sj.mp.4002101
137. Marcos B, Aisa B, Ramírez MJ, Functional interaction between 5-HT6 receptors and hypothalamic-pituitary-adrenal axis: Cognitive implications. Neuropharmacology 54, 708-714 (2008) DOI: 10.1016/j.neuropharm.2007.11.019
138. Martisova E, Aisa B, Guereñu G, Ramírez MJ, Effects of early maternal separation on biobehavioral and neuropathological markers of Alzheimer's disease in adult male rats. Curr Alzheimer Res 10, 420-432 (2013) DOI: 10.2174/1567205011310040007
139. Ivy AS, Rex CS, Chen Y, Dube C, Maras PM, Grigoriadis DE, Gall CM, Lynch G, Baram TZ, Hippocampal dysfunction and cognitive impairments provoked by chronic early-life stress involve excessive activation of CRH receptors. J Neurosci 30, 13005-13015 (2010) DOI: 10.1523/JNEUROSCI.1784-10.2010
140. Briones A, Gagno S, Martisova E, Dobarro M, Aisa B, Solas M, Tordera R, Ramírez M, Stress-induced anhedonia is associated with an increase in Alzheimer's disease-related markers. Br J Pharmacol 165, 897-907 (2012) DOI: 10.1111/j.1476-5381.2011.01602.x
141. Bowman RE, Beck KD, Luine VN, Chronic stress effects on memory: sex differences in performance and monoaminergic activity. Horm Behav 43, 48-59 (2003) DOI: 10.1016/S0018-506X(02)00022-3
142. Luine V, Sex differences in chronic stress effects on memory in rats. Stress 5, 205-216 (2002) DOI: 10.1080/1025389021000010549
143. Aisa B, Tordera R, Lasheras B, Del Río J, Ramírez MJ, Effects of maternal separation on hypothalamic-pituitary-adrenal responses, cognition and vulnerability to stress in adult female rats. Neurosci 154, 1218-1226 (2008) DOI: 10.1016/j.neuroscience.2008.05.011
144. Solas M, Gerenu G, Gil-Bea FJ, Ramírez MJ, Mineralocorticoid receptor activation induces insulin resistance through c-Jun N-terminal kinases in response to chronic corticosterone: cognitive implications. J Neuroendocrinol 25, 350-356 (2013) DOI: 10.1111/jne.12006
145. De Felice FG, Alzheimer's disease and insulin resistance: translating basic science into clinical applications. J Clin Invest 123, 531-539 (2013) DOI: 10.1172/JCI64595
146. De Senna PN, Ilha J, Baptista PPA, do Nascimento PS, Leite MC, Paim MF, Gonçalves CA, Achaval M, Xavier LL, Effects of physical exercise on spatial memory and astroglial alterations in the hippocampus of diabetic rats. Metab Brain Dis 26, 269-279 (2011) DOI: 10.1007/s11011-011-9262-x
147. Abbas T, Faivre E, Hölscher C, Impairment of synaptic plasticity and memory formation in GLP-1 receptor KO mice: Interaction between type 2 diabetes and Alzheimer's disease. Behav Brain Res 205, 265-271 (2009) DOI: 10.1016/j.bbr.2009.06.035
148. Faivre E, Hamilton A, Hölscher C, Effects of acute and chronic administration of GIP analogues on cognition, synaptic plasticity and neurogenesis in mice. Eur J Pharmacol 674, 294-306 (2012) DOI: 10.1016/j.ejphar.2011.11.007